Arun Sridhar
Arun Sridhar is a Doctoral Candidate at the CAG-IBD Research Group at the Norwegian University of Science and Technology in Trondheim, Norway.
His main research focus is investigating the effects of IBD-drug targets on Intestinal epithelial cells (IECs) with particular emphasis on elucidating the mode of action of various JAK/TYK2 inhibitors and their impact on epithelium. The aim is to advance the understanding of targeted IBD therapies and their mechanism at the cellular level.